Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

December 30, 2018

Conditions
Hypothyroidism
Interventions
DRUG

Levothyroxine

At first visit, after taking detailed history including baseline symptomatology, clinical evaluation, and laboratory investigation, treatment will be started with levothyroxine (50 microgram/day). The dosage of levothyroxine (LT4) will be adjusted (at 4th and 8th week) in an attempt to keep the serum FT4 and TSH concentrations within the normal range. After 12 weeks, all the patients will be followed up, clinical and laboratory tests will be repeated.

Trial Locations (1)

751019

AIIMS, Bhubaneswar, Bhubaneshwar

All Listed Sponsors
lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT02467244 - Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism | Biotech Hunter | Biotech Hunter